GlassScriptPhysician profile
Michael R Gonzalez Ramos
NPI 1922331933
$7,203.81
in general payments reported to CMS, 2019-2025
14 companies · $933 in 2025
The $933 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $179 · 2021: $254 · 2022: $2,628 · 2023: $380 · 2024: $2,455 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,288 · Education: $1,000 · Travel and Lodging: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,287.72 |
| Education | $1,000.00 |
| Travel and Lodging | $479.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,593.03 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $693.20 | 2020-2025 | Phasix Mesh |
| Conmed Corporation | $466.05 | 2021-2025 | Airseal |
| Smith+Nephew, INC. | $454.58 | 2022-2025 | Grafix Pl, Stravix, Stravix Pl |
| Sanara Medtech INC. | $252.95 | 2024-2025 | Celleraterx, Celleraterx |
| Allergan, INC. | $153.81 | 2019-2022 | |
| Stryker Corporation | $131.82 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $121.87 | 2025 | |
| Solventum Corporation | $120.46 | 2024 | V.A.C. Veraflo, Prevena |
| Polynovo North America LLC | $83.80 | 2025 | Novosorb Btm |
| Kci USA, INC. | $39.07 | 2020-2022 | |
| Ethicon US, LLC | $37.90 | 2019 | |
| Becton, Dickinson and Company | $33.33 | 2024 | Phasix Mesh |
| Mallinckrodt Hospital Products INC. | $21.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gonzalez Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.